346 related articles for article (PubMed ID: 4609223)
1. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
2. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
Zigmond MJ; Stricker EM
Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
[No Abstract] [Full Text] [Related]
3. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
4. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
5. On the accumulation of p-hydroxynorephedrine in noradrenaline neurons during chronic administration of amphetamine in the rat in relation to amphetamine tolerance.
Lewander T
Psychiatr Neurol Neurochir; 1972; 75(3):215-8. PubMed ID: 5064647
[No Abstract] [Full Text] [Related]
6. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine.
Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R
Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
[No Abstract] [Full Text] [Related]
8. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
[No Abstract] [Full Text] [Related]
9. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
Schoenfeld RI; Uretsky NJ
J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
[No Abstract] [Full Text] [Related]
10. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol.
Quattrone A; Bendotti C; Recchia M; Samanin R
Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765
[No Abstract] [Full Text] [Related]
11. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
Peterson DW; Sparber SB
J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
[No Abstract] [Full Text] [Related]
12. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
Moore KE
Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
[No Abstract] [Full Text] [Related]
13. Relationship of biogenic amines to behavior.
Breese GR; Cooper BR; Hollister AS
J Psychiatr Res; 1974; 11():125-33. PubMed ID: 4282384
[No Abstract] [Full Text] [Related]
14. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
Zigmond MJ; Stricker EM
Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of central action of octopamine.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
[TBL] [Abstract][Full Text] [Related]
16. Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats.
Phillips AG; Fibiger HC
Behav Biol; 1976 Feb; 16(2):127-43. PubMed ID: 1259675
[No Abstract] [Full Text] [Related]
17. Proceedings: Relationship of catecholamine neural systems to the behavioral alterations produced by 6-hydroxy-dopamine administration into brain.
Cooper BR; Breese GR
Psychopharmacol Bull; 1974 Jul; 10(3):39. PubMed ID: 4419434
[No Abstract] [Full Text] [Related]
18. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
Smith RD; Cooper BR; Breese GR
J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
[No Abstract] [Full Text] [Related]
19. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats.
Stricker EM; Zigmond MJ
J Comp Physiol Psychol; 1974 Jun; 86(6):973-94. PubMed ID: 4836848
[No Abstract] [Full Text] [Related]
20. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
Beuthin FC; Miya TS; Blake DE; Bousquet WF
J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
